U.S. stocks rallied on Monday as the U.S. dollar eased back from its recent peak and worries eased about the timing of a Federal Reserve interest rate hike.
Salix Pharmaceuticals
Breaking News
Billionaire investor William Ackman has purchased a five percent stake in Valeant Pharmaceuticals (VRX.TO) (VRX.N), his hedge fund said on Monday, making him the Canadian drug company's fifth-largest stakeholder.
Bloomberg report said Salix Pharmaceuticals has proposed a rate for the USD 1.2 billion financing it will be getting for the purchase of Santarus Inc.
Subscribe to VCpost newsletter
Most Popular
- Former CEO Shoots Himself to Commit Suicide After Receiving $25 Million Record-Breaking Fine for Fraud at Steinhoff
- Xi Jinping Warns Dutch PM That 'No Force' Can Stop China's Technological Advancement Amid Export Restrictions
- Businessman Brutally Murdered Allegedly by 4 of His Workers Who Swung an Axe Into His Head
- Taylor Swift Reaches Her Billionaire' Era,' Joining Elon Musk and Jeff Bezos on the List of World's Wealthiest People
- Major AI Companies Unite to Create the World's First Artificial Superintelligence Alliance Worth $7.6 Billion
- Disney Investor Nelson Peltz Criticizes the Company’s 'Woke' Strategy, Questioning 'Black Panther' and 'The Marvels' Films
- Four Deaths May Be Linked to Dietary Supplements Made by Japan’s Kobayashi Pharmaceutical: Report
- Alaska Airlines Passenger Loses Pet Dog During Loading Due to Airline Misstep